0000899243-21-036569.txt : 20210920 0000899243-21-036569.hdr.sgml : 20210920 20210920142940 ACCESSION NUMBER: 0000899243-21-036569 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210908 FILED AS OF DATE: 20210920 DATE AS OF CHANGE: 20210920 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BHATIA NAVEEN CENTRAL INDEX KEY: 0001452171 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39785 FILM NUMBER: 211262921 MAIL ADDRESS: STREET 1: 823 GREENTREE RD CITY: PACIFIC PALISADES STATE: CA ZIP: 90272 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LifeMD, Inc. CENTRAL INDEX KEY: 0000948320 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 760238453 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 800 THIRD AVENUE, SUITE 2800 CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (866) 351-5907 MAIL ADDRESS: STREET 1: 800 THIRD AVENUE, SUITE 2800 CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: CONVERSION LABS, INC. DATE OF NAME CHANGE: 20180622 FORMER COMPANY: FORMER CONFORMED NAME: Immudyne, Inc. DATE OF NAME CHANGE: 20120514 FORMER COMPANY: FORMER CONFORMED NAME: IMMUDYNE INC DATE OF NAME CHANGE: 19950720 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-09-08 0 0000948320 LifeMD, Inc. LFMD 0001452171 BHATIA NAVEEN 823 GREENTREE RD PACIFIC PALISADES CA 90272 1 0 0 0 Common Stock 2021-09-15 4 X 0 96349 1.75 A 96349 D Stock Option (Right to Buy) 7.07 2021-09-08 4 A 0 100000 0.00 A 2021-09-08 2021-09-08 Common Stock 100000 100000 D Restricted Stock Unit 0.00 2021-09-08 4 A 0 8000 0.00 A Common Stock 8000 8000 D Warrant (Right to Buy) 1.75 2021-09-15 4 G 0 96349 0.00 A 2021-09-15 2022-01-12 Common Stock 96349 96349 D Warrant (Right to Buy) 1.75 2021-09-15 4 X 0 96349 0.00 D 2021-09-15 2022-01-12 Common Stock 96349 0 D Pursuant to the Company's 2020 Equity and Incentive Plan, as amended, the Director received a one-time grant of 8,000 Restricted Stock Units ("RSUs"), vesting quarterly with 25% vesting on September 30, 2021 and the remaining vesting ratably on December 31, 2021, March 31, 2022 and on the earlier of the annual stockholders' meeting or June 30, 2022. The RSUs represent a contingent right to receive one share of Common Stock for each RSU. Mr. Bhatia received an option to purchase 100,000 shares of Common Stock, at an exercise price of $7.07 per share, as compensation for services to be provided pursuant to a Consulting Agreement dated September 8, 2021. /s/ Naveen Bhatia 2021-09-20